Finance

Beta
Lists
4978:TYO
ReproCell Inc
¥125.00
+1.63%
(+2.00) 1D
Jun 3, 1:39:48 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4978...
Open
¥124
High
¥126
Low
¥121
Mkt. cap
11.89B
Avg. vol.
527.24K
Volume
313.80K
52-wk high
¥242
52-wk low
¥121
EPS
-¥6
Shares outstanding
71.07M
No. of employees
99
Open
¥124
High
¥126
Low
¥121
Mkt. cap
11.89B
Avg. vol.
527.24K
Volume
313.80K
52-wk high
¥242
52-wk low
¥121
EPS
-¥6
Shares outstanding
71.07M
No. of employees
99
News stories
From sources across the web
About ReproCell Inc
CEO-
Employees99
FoundedFeb 26, 2003
Headquarters-
SectorBiotechnology
Websitereprocell.com
Last report
May 14, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
624.00M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
475.00M
499.00M
635.00M
624.00M
Cost of goods sold
281.00M
306.00M
310.00M
321.00M
Cost of revenue
281.00M
306.00M
310.00M
321.00M
Research and development expenses
162.00M
146.00M
157.00M
162.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
323.00M
302.00M
299.00M
324.00M
Operating expense
485.00M
448.00M
456.00M
486.00M
Total operating expenses
766.00M
754.00M
766.00M
807.00M
Operating income
-291.00M
-255.00M
-131.00M
-183.00M
Other non operating income
-
-1.00M
102.00M
9.00M
EBT including unusual items
-302.00M
-182.00M
29.00M
-132.00M
EBT excluding unusual items
-302.00M
-182.00M
29.00M
-126.00M
Income tax expense
2.00M
-
1.00M
1.00M
Effective tax rate
-0.66%
-
3.45%
-0.76%
Other operating expenses
-
-
-
-
Net income
-304.00M
-182.00M
28.00M
-133.00M
Net profit margin
-64.00%
-36.47%
4.41%
-21.31%
Earnings per share
-
-
-
-
Interest and investment income
16.00M
25.00M
17.00M
29.00M
Interest expense
-
-
-
-
Net interest expenses
16.00M
25.00M
17.00M
29.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-278.75M
-238.00M
-118.75M
-164.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer